Wednesday, May 01, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

NEWS

Genetic Engineering Center focuses on public health in Cuba

Camagüey, Cuba, Apr 4 (Prensa Latina) One of the most important institutions of science in Cuba, the Center for Genetic Engineering and Biotechnology (CIGB) of Camagüey, continues today with several projects to solve the difficulties in key sectors.

In a meeting with U.S. professors at the Academic Exchange Research Searches, organized by the University of Camagüey (UC), the visitors were able to know how much work is being done on the island to make research one of the main fruits of progress.

In addition to medicines and products already with a registered trademark, such as the vaccine for the control of ticks Gavac, or HeberNem, used in areas such as agriculture, now the collective, founded in 1989 by Fidel Castro, is focusing on another product.

This was expressed by Nemesio Gonzalez, director of the CIGB, ‘it is a novel project based on the use of Interferon and combinations for the treatment of non-melanoma type cancer in skin cancer’, he said.

The researcher told those present that ‘interferon was the first product manufactured at the Center for Genetic Engineering and Biotechnology of Cuba.

The interferon, the molecule, the product is the result of a later development’.

Gonzalez expressed that ‘after many tests and application to humans, we obtained very good results in clinical trials’.

In a second moment, he referred to another project.

This is a new product, but it does not yet have a commercial name, because it is still in the testing phase.

It is a neuroprotector that is used to protect people from cerebral infarction.

It is also possible to see the evaluation of the patients after a heart attack, how they recover after treatment with this product,’ he said.

The intentions of improvement are not limited to the above, since the administrator added to the agenda ‘another example, which is Herbersavax, a Cuban vaccine candidate for cancer treatment’.

It is a product that combines two molecules with the aim of reducing the proliferation of blood vessels that feed cancerous tumors’, the researcher also gave details.

It is necessary to point out the role of the Center during Covid-19.

These are products that were also used during the pandemic.

The Cuban Interferon Alfa was the first one applied to a patient worldwide who suffered from Covid-19, this was done in China because our plant is located in that nation’, he said.

ef/abo/ro/fam

LATEST NEWS
RELATED